AbbVie Inc said Thursday that it is preparing for potential pharmaceutical sector tariffs, warning investors that trade headwinds could impact financial performance later this year

AbbVie said on Monday it would buy biotech Apogee Therapeutics for $10.9 billion in cash, as the U.S. drugmaker builds its next-generation immunology pipeline

Eli Lilly's Mounjaro Receives FDA Approval for Heart Disease Treatment

Eli Lilly Reports Strong Q2 Results with Higher EPS and Revenue

AbbVie Reports Strong Q2 Earnings with Positive Revenue Surprises